EGA Institute for Women's Health, Faculty of Population Health Sciences, University College London, London, UK.
Clinic for Gynecology and Perinatology, University Medical Center Maribor, Maribor, Slovenia.
Ultrasound Obstet Gynecol. 2024 Sep;64(3):405-411. doi: 10.1002/uog.27607. Epub 2024 Aug 7.
To determine the natural progression of ovarian endometrioma in women who are managed expectantly.
This was a retrospective cohort study of 83 women with evidence of ovarian endometrioma who were managed expectantly between April 2007 and May 2022. The study was conducted in the Department of Women's Health, University College London Hospitals and The Gynecology Ultrasound Centre, London, UK. We searched our ultrasound clinic databases to identify women aged 18 years or older with evidence of ovarian endometrioma who were managed expectantly for ≥ 6 months. All women attended for a minimum of two ultrasound scans performed by a single expert ultrasound operator. In addition to patient demographics, we recorded the number, mean diameter and location of each cyst. The cyst growth rate was expressed as annual change in the mean diameter.
A total of 1922 women who attended our gynecology clinic during the study period were found to have evidence of moderate or severe endometriosis on pelvic ultrasound examination. Of those, 83 women had evidence of ovarian endometrioma and were managed expectantly. The median age of women was 39 (range, 26-51) years at the initial visit. Each woman had at least two ultrasound scans performed by a single expert operator at a minimum interval of ≥ 6 months. Of 83 women diagnosed with endometrioma, 50 (60% (95% CI, 49-71%)) had a single cyst and the remainder had multiple cysts. The median number of endometriomas per patient was 1 (range, 1-5) and the median follow-up time was 634 (range, 187-2984) days. A total of 39/83 (47% (95% CI, 36-58%)) women experienced an overall reduction in size of cysts, in 18/83 (22% (95% CI, 13-32%)) the cysts increased in size and in 26/83 (31% (95% CI, 22-42%)) women, no meaningful change in size was observed. The median change in mean cyst diameter per woman during the study period was -2.7 (range, -57.7 to 39.3) mm, with a median annual regression rate of -1.7 (range, -24.6 to 42.0) mm/year/woman. Overall, when compared with the initial visit, cysts were significantly smaller at follow-up (median diameter, 22.3 (range, 6.7-77.0) mm vs 18.5 (range, 5.0-72.0) mm; P = 0.009). We did not identify any clinical characteristics that could reliably predict the chance of endometrioma progression.
In the majority of women with an ultrasound diagnosis of ovarian endometrioma, the cysts do not increase in size significantly over time and they could be managed expectantly. This evidence may help clinicians when counseling asymptomatic or minimally symptomatic women about management of ovarian endometrioma. © 2024 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
确定期待治疗的卵巢子宫内膜异位症患者的自然病程。
这是一项回顾性队列研究,共纳入 83 例有卵巢子宫内膜异位症证据且期待治疗≥6 个月的女性。研究在英国伦敦大学学院医院妇女健康系和妇科超声中心进行。我们检索了我们的超声诊所数据库,以确定年龄在 18 岁或以上、有卵巢子宫内膜异位症证据且接受期待治疗的女性。所有女性均至少接受了两次超声检查,由一名经验丰富的超声医师操作。除患者人口统计学数据外,我们还记录了每个囊肿的数量、平均直径和位置。囊肿生长速度用平均直径的年变化来表示。
在研究期间,我们在妇科诊所就诊的 1922 名女性中有 1922 名被发现盆腔超声检查有中重度子宫内膜异位症证据。其中 83 例女性有卵巢子宫内膜异位症证据并接受期待治疗。女性的中位年龄为 39(范围 26-51)岁。每位女性在至少 6 个月的时间间隔内至少接受了两次由单一专家操作的超声检查。在诊断为子宫内膜异位症的 83 例女性中,50 例(60%(95%CI,49%-71%))有单个囊肿,其余有多个囊肿。每位患者的平均子宫内膜异位瘤数为 1(范围 1-5),中位随访时间为 634(范围 187-2984)天。共有 39/83(47%(95%CI,36%-58%))例女性的囊肿总体缩小,18/83(22%(95%CI,13%-32%))例女性的囊肿增大,26/83(31%(95%CI,22%-42%))例女性的囊肿无明显变化。研究期间,每位女性的平均囊肿直径中位数变化为-2.7(范围,-57.7 至 39.3)mm,中位数年回归率为-1.7(范围,-24.6 至 42.0)mm/年/女性。总体而言,与初次就诊相比,随访时囊肿明显变小(直径中位数,22.3(范围,6.7-77.0)mm 与 18.5(范围,5.0-72.0)mm;P=0.009)。我们没有发现任何能够可靠预测子宫内膜异位症进展机会的临床特征。
在大多数有卵巢子宫内膜异位症超声诊断的女性中,囊肿的大小不会随时间显著增加,因此可以进行期待治疗。这一证据可能有助于临床医生在对无症状或症状轻微的女性进行卵巢子宫内膜异位症管理的咨询时提供参考。© 2024 作者。约翰威立父子出版公司代表国际妇产科超声学会在超声医学杂志上发表。